The protective effects against IBD risk (OR: 1.20 (1.09–1.33); P = 1.70E-04) and CD risk (OR: 1.26 (1.11–1.43); P = 2.60E-04) were similar when the genetic variation in TG levels was modified by LPL. Here, LPL is linked to inflammatory bowel disease.